METHODS: This pilot randomised controlled trial will run at the three tertiary paediatric rehabilitation services in New South Wales, Australia. A total of 120 participants will be recruited, with randomisation stratified by study site. A survey tool will be used to identify families experiencing unmet social needs. Parents/caregivers who report one or more unmet social need/s and consent will be eligible. The active control group will receive a resource pack containing information on community services to support unmet social needs. The social prescribing intervention group will receive one-on-one Community Linker support, in addition to the resource pack. The survey tool, intervention, logic model, and resource pack were co-designed with patient families and their healthcare workers. Feasibility of the research design and the clinical pathways will be evaluated using the number/proportion of parents/caregivers who complete the survey tool, consent, engage with the intervention, and complete research measures. Acceptability will be evaluated using questionnaires and qualitative interviews.
BACKGROUND: Human research ethics approval was granted by the Sydney Children\'s Hospitals Network Human Research Ethics Committee (2022/ETH01688). Participants and stakeholders will receive updates and findings via regular communication channels including meetings, presentations, and publications.
BACKGROUND: Australia New Zealand Clinical Trials Registry: 12622001459718.
方法:这项试点随机对照试验将在新南威尔士州的三个三级儿科康复服务机构进行,澳大利亚。共招募120名参加者,随机分组按研究地点分层。将使用调查工具来识别未满足社会需求的家庭。报告一个或多个未满足的社会需求和同意的父母/照顾者将有资格。主动对照组将收到一个资源包,其中包含有关社区服务的信息,以支持未满足的社会需求。社会处方干预小组将获得一对一的社区链接支持,除了资源包。调查工具,干预,逻辑模型,和资源包是与患者家属及其医护人员共同设计的。研究设计和临床路径的可行性将使用完成调查工具的父母/照顾者的数量/比例进行评估,同意,参与干预,并完成研究措施。可接受性将使用问卷和定性访谈进行评估。
背景:悉尼儿童医院网络人类研究伦理委员会(2022/ETH01688)批准了人类研究伦理。参与者和利益相关者将通过定期沟通渠道,包括会议,介绍,和出版物。
背景:澳大利亚新西兰临床试验注册:12622001459718。